revisionesencancer2020.grupoaran[.]com
Forensic brief
PhishDestroy identifies revisionesencancer2020.grupoaran.com as a high-risk generic phishing domain. Such threats aim to deceive users into revealing sensitive information, posing serious security risks. This domain was registered on February 21, 2026, but is currently offline. It appeared on one security blocklist and was flagged by multiple security vendors on VirusTotal. The domain was registered through a now-dead registrar, indicating potentially malicious intent. Users are advised to avoid visiting this domain or providing any personal data. Always verify website legitimacy and use updated security tools to detect phishing attempts.
Threat response pipeline
VirusTotal
Forensic Evidence CollectionEvidence capture
Domain Intelligence
Technical details
Public blocklist status
VirusTotal consensus
Aggregated detection across 12 security vendors.
Evidence & external reports
Were you affected by this site?
Were You Affected?
Recommendations & Advice for Victims
- Do not pay anything else. Recovery agents demanding upfront fees are a second-stage scam.
- Disconnect compromised wallets. Move remaining funds to a fresh seed phrase generated offline.
- Preserve evidence. Screenshot transactions, save URLs, archive emails — chain-of-custody matters for prosecution.
- Report to authorities (see section 15 below) — even small reports help build case patterns.
- Notify your bank/exchange. Some chargebacks may still be possible within 24-72h.
Report to your local authorities
Email template — registrar abuse
abuse@
Case: PD-
Embed this report
About this report
About this report: revisionesencancer2020.grupoaran.com
This domain security report is maintained by PhishDestroy's automated threat-intelligence pipeline. Our system continuously monitors this domain across 12 security vendors on VirusTotal and 1 public blocklists.
The site displays a page titled “One Drive”.
revisionesencancer2020.grupoaran.com has been flagged by 12 security vendors as of May 17, 2026.
If you believe this listing is inaccurate, you can submit an appeal. For more information about our methodology, visit our FAQ page.